Supplementation of 1 g hesperidin capsule for 12 weeks significantly reduced alanine aminotransferase (ALT), γ‐glutamyltransferase, total cholesterol, triglyceride, and hepatic steatosis in MASLD patients [197]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.